Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-12-13 07:27 UTC (UTC+2h)
 

Drug accountability is tricky business [Off Topic]

posted by ElMaestro - Denmark, 2017-04-07 15:35  - Posting: # 17233
Views: 595

Hi all,

I have to admit, when I audit or inspect I always do D.A. 'by manual count' if circumstances allow, and I usually do not get it right in the first attempt. It usually takes several tries and re-reading of dosing forms, receipt records, pharmacy binders etc., before the figures check out even though this is only a matter of addition and subtraction. It is rather comforting to see that I am not the only one who is occasionally struggling.

:-D:-D:-D
Wishing you all a good weekend.

I could be wrong, but…


Best regards,
ElMaestro

A potentially biased estimator may be a relevant estimator. The case of REML speaks volumes.

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,556 Posts in 3,758 Threads, 1,091 registered users;
28 users online (0 registered, 28 guests).

The purpose of models is not to fit the data,
but to sharpen the questions.    Samuel Karlin

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed